These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 18373080)

  • 1. Diabetes Antibody Standardization Program: evaluation of assays for autoantibodies to glutamic acid decarboxylase and islet antigen-2.
    Törn C; Mueller PW; Schlosser M; Bonifacio E; Bingley PJ;
    Diabetologia; 2008 May; 51(5):846-52. PubMed ID: 18373080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of serum and EDTA plasma in the measurement of glutamic acid decarboxylase autoantibodies (GADA) and autoantibodies to islet antigen-2 (IA-2A) using the RSR radioimmunoassay (RIA) and enzyme linked immunosorbent assay (ELISA) kits.
    Rahmati K; Lernmark A; Becker C; Foltyn-Zadura A; Larsson K; Ivarsson SA; Törn C
    Clin Lab; 2008; 54(7-8):227-35. PubMed ID: 18942490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diabetes Antibody Standardization Program: evaluation of assays for insulin autoantibodies.
    Schlosser M; Mueller PW; Törn C; Bonifacio E; Bingley PJ;
    Diabetologia; 2010 Dec; 53(12):2611-20. PubMed ID: 20871974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetes Antibody Standardization Program: first assay proficiency evaluation.
    Bingley PJ; Bonifacio E; Mueller PW
    Diabetes; 2003 May; 52(5):1128-36. PubMed ID: 12716742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Harmonization of glutamic acid decarboxylase and islet antigen-2 autoantibody assays for national institute of diabetes and digestive and kidney diseases consortia.
    Bonifacio E; Yu L; Williams AK; Eisenbarth GS; Bingley PJ; Marcovina SM; Adler K; Ziegler AG; Mueller PW; Schatz DA; Krischer JP; Steffes MW; Akolkar B
    J Clin Endocrinol Metab; 2010 Jul; 95(7):3360-7. PubMed ID: 20444913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prevalence of early subclinical somatic neuropathy in children and adolescents with Type 1 diabetes mellitus and its association with the persistence of autoantibodies to glutamic acid decarboxylase (GAD) and islet antigen-2 (IA-2).
    Louraki M; Katsalouli M; Kanaka-Gantenbein C; Kafassi N; Critselis E; Kallinikou D; Tsentidis C; Karavanaki K
    Diabetes Res Clin Pract; 2016 Jul; 117():82-90. PubMed ID: 27329026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diabetes Antibody Standardization Program: First evaluation of assays for autoantibodies to IA-2β.
    Schlosser M; Mueller PW; Achenbach P; Lampasona V; Bingley PJ;
    Diabetes Care; 2011 Nov; 34(11):2410-2. PubMed ID: 21926293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. International Workshop on Lessons From Animal Models for Human Type 1 Diabetes: identification of insulin but not glutamic acid decarboxylase or IA-2 as specific autoantigens of humoral autoimmunity in nonobese diabetic mice.
    Bonifacio E; Atkinson M; Eisenbarth G; Serreze D; Kay TW; Lee-Chan E; Singh B
    Diabetes; 2001 Nov; 50(11):2451-8. PubMed ID: 11679421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of measurements of autoantibodies to glutamic acid decarboxylase and islet antigen-2 in whole blood eluates from dried blood spots using the RSR-enzyme linked immunosorbent assay kits and in-house radioimmunoassays.
    Persson A; Becker C; Hansson I; Nilsson A; Törn C
    Exp Diabetes Res; 2010; 2010():173652. PubMed ID: 20613950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 3 Screen islet cell autoantibody ELISA: A sensitive and specific ELISA for the combined measurement of autoantibodies to GAD
    Amoroso M; Achenbach P; Powell M; Coles R; Chlebowska M; Carr L; Furmaniak J; Scholz M; Bonifacio E; Ziegler AG; Rees Smith B
    Clin Chim Acta; 2016 Nov; 462():60-64. PubMed ID: 27570064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Islet Autoantibody Standardization Program 2018 Workshop: Interlaboratory Comparison of Glutamic Acid Decarboxylase Autoantibody Assay Performance.
    Lampasona V; Pittman DL; Williams AJ; Achenbach P; Schlosser M; Akolkar B; Winter WE;
    Clin Chem; 2019 Sep; 65(9):1141-1152. PubMed ID: 31409598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LIPS islet autoantibody assays in high-throughput format for DASP 2010.
    Marcus P; Yan X; Bartley B; Hagopian W
    Diabetes Metab Res Rev; 2011 Nov; 27(8):891-4. PubMed ID: 22069280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Islet autoantibodies present in association with Ljungan virus infection in bank voles (Myodes glareolus) in northern Sweden.
    Warvsten A; Björnfors M; Arvidsson M; Vaziri-Sani F; Jönsson I; Olsson GE; Ahlm C; Larsson HE; Lernmark Å; Nilsson AL
    J Med Virol; 2017 Jan; 89(1):24-31. PubMed ID: 27283793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of two nonisotopic immunoassays for determination of glutamic acid decarboxylase and tyrosine phosphatase autoantibodies in serum.
    Palomer X; Mauricio D; Rodríguez-Espinosa J; Zapico E; Mayoral C; González-Sastre F; de Leiva A; Blanco-Vaca F
    Clin Chem; 2004 Aug; 50(8):1378-82. PubMed ID: 15155543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoantibodies to GAD and IA-2 in Saudi Arabian diabetic patients.
    Damanhouri LH; Dromey JA; Christie MR; Nasrat HA; Ardawi MS; Robins RA; Todd I
    Diabet Med; 2005 Apr; 22(4):448-52. PubMed ID: 15787671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of a rapid type 1 diabetes autoantibody screening assay for community-based screening of organ donors to identify subjects at increased risk for the disease.
    Wasserfall C; Montgomery E; Yu L; Michels A; Gianani R; Pugliese A; Nierras C; Kaddis JS; Schatz DA; Bonifacio E; Atkinson MA
    Clin Exp Immunol; 2016 Jul; 185(1):33-41. PubMed ID: 27029857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Absence of avidity maturation of autoantibodies to the protein tyrosine phosphatase-like IA-2 molecule and glutamic acid decarboxylase (GAD65) during progression to type 1 diabetes.
    Westerlund A; Ankelo M; Ilonen J; Knip M; Simell O; Hinkkanen AE
    J Autoimmun; 2005 Mar; 24(2):153-67. PubMed ID: 15829408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seroconversion to islet autoantibodies between early pregnancy and delivery in non-diabetic mothers.
    Lindehammer SR; Hansson I; Midberg B; Ivarsson SA; Lynch KF; Dillner J; Lernmark A;
    J Reprod Immunol; 2011 Jan; 88(1):72-9. PubMed ID: 21111487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measurement of islet cell antibodies in the Type 1 Diabetes Genetics Consortium: efforts to harmonize procedures among the laboratories.
    Bingley PJ; Williams AJ; Colman PG; Gellert SA; Eisenbarth G; Yu L; Perdue LH; Pierce JJ; Hilner JE; Nierras C; Akolkar B; Steffes MW;
    Clin Trials; 2010; 7(1 Suppl):S56-64. PubMed ID: 20693189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IA-2 antibody prevalence and risk assessment of early insulin requirement in subjects presenting with type 2 diabetes (UKPDS 71).
    Bottazzo GF; Bosi E; Cull CA; Bonifacio E; Locatelli M; Zimmet P; Mackay IR; Holman RR
    Diabetologia; 2005 Apr; 48(4):703-8. PubMed ID: 15765222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.